Nuclear Pharma Danmark ApS — Credit Rating and Financial Key Figures
CVR number: 37815578
Langholts Ager 2, 8300 Odder
Income statement (kDKK)
2016 | 2017 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | -20.95 | -6.00 |
| EBIT | -20.95 | -6.00 |
| Other financial income | 3.40 | |
| Other financial expenses | -0.25 | -2.67 |
| Pre-tax profit | -21.20 | -5.27 |
| Net earnings | -21.20 | -5.27 |
Assets (kDKK)
2016 | 2017 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Investments total | ||
| Long term receivables total | ||
| Finished products/goods | 103.09 | |
| Inventories total | 103.09 | |
| Current other receivables | -51.55 | 34.00 |
| Short term receivables total | -51.55 | 34.00 |
| Balance sheet total (assets) | 51.55 | 34.00 |
Equity and liabilities (kDKK)
2016 | 2017 | |
|---|---|---|
| Share capital | 50.00 | 50.00 |
| Retained earnings | 1.55 | -19.65 |
| Profit of the financial year | -21.20 | -5.27 |
| Shareholders equity total | 30.35 | 25.07 |
| Non-current liabilities total | ||
| Current trade creditors | 6.25 | 6.25 |
| Other non-interest bearing current liabilities | 14.95 | 2.67 |
| Current liabilities total | 21.20 | 8.92 |
| Balance sheet total (liabilities) | 51.55 | 34.00 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.